Plasma membrane alterations and cytoskeletal changes in apoptosis

被引:167
作者
vanEngeland, M
Kuijpers, HJH
Ramaekers, FCS
Reutelingsperger, CPM
Schutte, B
机构
[1] UNIV LIMBURG,DEPT MOL CELL BIOL & GENET,NL-6200 MD MAASTRICHT,NETHERLANDS
[2] UNIV LIMBURG,DEPT BIOCHEM,NL-6200 MD MAASTRICHT,NETHERLANDS
关键词
D O I
10.1006/excr.1997.3738
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During apoptosis, one of the first membrane changes that can be detected is exposure of phosphatidylserine residues at the outer plasma membrane leaflet, while early apoptosis is also accompanied by changes in the cytoskeletal organization. In this study we investigated the relationship between these two phenomena during olomoucine- and rescovitin-induced apoptosis in human lung cancer and neuroblastoma cell lines. Loss of membrane asymmetry was detected by biotin-labeled or FITC-labeled annexin V binding to negatively charged phosphatidylserine, while cytoskeletal components were visualized by immunocytochemistry. The apoptotic, annexin V-positive, cells were analyzed by flow cytometry, confocal scanning laser microscopy, and Western blotting. We report that cytokeratin and vimentin aggregation in early apoptosis occurs simultaneously with phosphatidylserine exposure and chromatin condensation. In contrast to these intermediate filament proteins, which were disassembled and proteolytically cleaved in early apoptosis, microfilaments and microtubuli were not proteolytically degraded but were found to be present as aggregated filaments in the apoptotic bodies. We also show that loss of membrane asymmetry and cytokeratin aggregation are independent processes, since N-ethylmaleimide-induced phosphatidylserine exposure does not cause cytokeratin disassembly. Vice versa, phorbol 12-myristate 13-acetate-induced cytokeratin filament aggregation does not result in phosphatidylserine exposure. (C) 1997 Academic Press.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 52 条
[51]  
Wyllie A H, 1980, Int Rev Cytol, V68, P251
[52]   APOPTOSIS (THE 1992 ROSE,FRANK MEMORIAL LECTURE) [J].
WYLLIE, AH .
BRITISH JOURNAL OF CANCER, 1993, 67 (02) :205-208